Inventor · disambiguated record
Michele Ann Mctigue
Also filed as: MCTIGUE MICHELE A · MCTIGUE MICHELE ANN
12 granted patents·3 pending applications·99 citations·filing 1999–2023
89Inventor score
Top patents by PatentIndex Score
15 records- 0195US8680111B2Macrocyclic derivatives for the treatment of diseasesPFIZER·Filed 2013·Granted Mar 25, 2014·54 cites·18 claims
- 0289US9133215B2Macrocyclic derivatives for the treatment of diseasesPFIZER·Filed 2014·Granted Sep 15, 2015·16 cites·18 claims
- 0384US10428104B2Substituted nucleoside derivatives useful as anticancer agentsPFIZER·Filed 2016·Granted Oct 1, 2019·6 cites·3 claims
- 0483US10220037B2Substituted carbonucleoside derivatives useful as anticancer agentsPFIZER·Filed 2017·Granted Mar 5, 2019·4 cites·17 claims
- 0581US11684616B2Azalactam compounds as HPK1 inhibitorsPFIZER·Filed 2021·Granted Jun 27, 2023·1 cites·33 claims
- 0678US10709709B2Substituted carbonucleoside derivatives useful as anticancer agentsPFIZER·Filed 2018·Granted Jul 14, 2020·1 cites·14 claims
- 0770US6316603B1Modifications of the VEGF receptor-2 protein and methods of useAGOURON PHARMA·Filed 1999·Granted Nov 13, 2001·15 cites·10 claims
- 0867US2024197703A1Azalactam Compounds as HPK1 InhibitorsPFIZER·Filed 2023·Application pending·0 cites
- 0960US2005197492A1Crystal structure of VEGFRKD: ligand complexes and methods of use thereofAGOURON PHARMA·Filed 2004·Application pending·0 cites
- 1056US6794146B2Modifications of the VEGF receptor-2 protein and methods of useAGOURON PHARMA·Filed 2001·Granted Sep 21, 2004·0 cites·2 claims
- 1150US6849721B2Modifications of the VEGF receptor-2 protein and methods of useAGOURON PHARMA·Filed 2001·Granted Feb 1, 2005·1 cites·7 claims
- 1250US6784285B1Modifications of the VEGF Receptor-2 Protein and methods of useAGOURON PHARMA·Filed 2000·Granted Aug 31, 2004·1 cites·4 claims
- 1344US11142525B2Azalactam compounds as HPK1 inhibitorsPFIZER·Filed 2019·Granted Oct 12, 2021·0 cites·40 claims
- 1441US6753416B2Modifications of the VEGF receptor-2 protein and methods of useAGOURON PHARMA·Filed 2001·Granted Jun 22, 2004·0 cites·2 claims
- 1539US2004009568A1Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase, and materials and methods for identification of inhibitors thereofFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michele Ann Mctigue files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →